Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Marc Miravitlles, Alexandra Solé, Helena Aguilar, Ana Ampudia, Jaume Costa-Samarra, Maria Mallén-Alberdi & Diana Nieves. (2021) Economic Impact of Low Adherence to COPD Management Guidelines in Spain. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3131-3143.
Read now
Read now
Francesco Blasi, Raffaele Antonelli Incalzi, Giorgio Walter Canonica, Pietro Schino, Giuseppina Cuttitta, Alessandro Zullo, Alessandra Ori & Nicola Scichilone. (2021) Clinical Evolution and Quality of Life in Clinically Based COPD Chronic Bronchitic and Emphysematous Phenotypes: Results from the 1-Year Follow-Up of the STORICO Italian Observational Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2133-2148.
Read now
Read now
Kristian Brat, Michal Svoboda, Jaromir Zatloukal, Marek Plutinsky, Eva Volakova, Patrice Popelkova, Barbora Novotna, Tomas Dvorak & Vladimir Koblizek. (2021) The Relation Between Clinical Phenotypes, GOLD Groups/Stages and Mortality in COPD Patients – A Prospective Multicenter Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1171-1182.
Read now
Read now
Raffaele Antonelli Incalzi, Francesco Blasi, Nicola Scichilone, Alessandro Zullo, Lucia Simoni & Giorgio Walter Canonica. (2021) One-Year Evolution of Symptoms and Health Status of the COPD Multi-Dimensional Phenotypes: Results from the Follow-Up of the STORICO Observational Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1007-1020.
Read now
Read now
Surinder Jindal & Aditya Jindal. (2021) COPD in Biomass exposed nonsmokers: a different phenotype. Expert Review of Respiratory Medicine 15:1, pages 51-58.
Read now
Read now
Melanie Schroeder, Nicole Benjamin, Laura Atienza, Chandroday Biswas, Alan Martin, John D Whalen, José Luis Izquierdo Alonso, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Alicia Huerta & Afisi S Ismaila. (2020) Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1621-1632.
Read now
Read now
Alexa Núñez, Cristina Esquinas, Miriam Barrecheguren, Myriam Calle, Ricard Casamor & Marc Miravitlles. (2018) Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3837-3844.
Read now
Read now
Julio Hernández Vázquez, Ismael Ali García, Rodrigo Jiménez-García, Alejandro Álvaro Meca, Ana López de Andrés, Carmen Matesanz Ruiz, María Jesús Buendía García & Javier de Miguel Díez. (2018) COPD phenotypes: differences in survival. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2245-2251.
Read now
Read now
Rafael Golpe, María Suárez-Valor, Irene Martín-Robles, Pilar Sanjuán-López, Esteban Cano-Jiménez, Olalla Castro-Añón & Luis A Pérez de Llano. (2018) Mortality in COPD patients according to clinical phenotypes. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1433-1439.
Read now
Read now
Bernardino Alcázar-Navarrete, Juan Antonio Trigueros, Juan Antonio Riesco, Anna Campuzano & Joselín Pérez. (2018) Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: “the ESPIRAL-ES study”. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1115-1124.
Read now
Read now
Marc Miravitlles, Jesús Molina, José Antonio Quintano, Anna Campuzano, Joselín Pérez & Carlos Roncero. (2018) Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 823-831.
Read now
Read now
Aleksander Kania, Rafał Krenke, Krzysztof Kuziemski, Małgorzata Czajkowska-Malinowska, Natalia Celejewska-Wójcik, Barbara Kuźnar-Kamińska, Małgorzata Farnik, Juliusz Bokiej, Marta Miszczuk, Iwona Damps-Konstańska, Marcin Grabicki, Marzena Trzaska-Sobczak, Krzysztof Sładek, Halina Batura-Gabryel & Adam Barczyk. (2018) Distribution and characteristics of COPD phenotypes – results from the Polish sub-cohort of the POPE study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1613-1621.
Read now
Read now
Articles from other publishers (26)
Juan Marco Figueira-Gonçalves, José María Hernández-Pérez, Carlos Cabrera-López, Aurelio Luis Wangüemert-Pérez, Ignacio García-Talavera, Yolanda Ramallo-Fariña, Carolina Ramos-Izquierdo, Luis Manuel González-García & Sara Guanche-Dorta. (2022) Characteristics of patients referred to Canary Island pneumology outpatient services for chronic obstructive pulmonary disease: the EPOCan study. BMC Research Notes 15:1.
Crossref
Crossref
S.K. Jinda. (2022) Phenotyping of Airway Diseases – ‘One Size Fits the Most – But Some Are Different’. The Indian Journal of Chest Diseases and Allied Sciences 61:1, pages 5-6.
Crossref
Crossref
X. Flor-Escriche, A. Sanz Bas, S. Álvarez Álvarez, V. Zamora Putin & M. Monteagudo Zaragoza. (2022) Riesgos, fenotipos y comparación de tratamiento de EPOC en atención primaria según guías GOLD y GesEPOC. Medicina de Familia. SEMERGEN 48:8, pages 101839.
Crossref
Crossref
Đivo Ljubičić, Vedran Balta, Dario Dilber, Hrvoje Vražić, Domagoj Đikić, Dyana Odeh, Jasna Čerkez Habek, Emilija Lozo Vukovac & Neven Tudorić. (2022) Association of chronic inflammation with cardiovascular risk in chronic obstructive pulmonary disease—A cross‐sectional study. Health Science Reports 5:3.
Crossref
Crossref
E. M. Teixeira, A. J. Lopes & P. L. Melo. 2022. XXVII Brazilian Congress on Biomedical Engineering. XXVII Brazilian Congress on Biomedical Engineering
285
291
.
Roberto W. Dal Negro, Mauro Carone, Giuseppina Cuttitta, Luca Gallelli, Massimo Pistolesi, Salvatore Privitera, Piero Ceriana, Pietro Pirina, Bruno Balbi, Carlo Vancheri, Franca M. Gallo, Alfredo Chetta, Paola Turco & On behalf of the CLIMA Study Group*. (2021) Prevalence and clinical features of most frequent phenotypes in the Italian COPD population: the CLIMA Study. Multidisciplinary Respiratory Medicine 16.
Crossref
Crossref
Yiming Ma, Yingjiao Long & Yan Chen. (2021) Roles of Inflammasome in Cigarette Smoke-Related Diseases and Physiopathological Disorders: Mechanisms and Therapeutic Opportunities. Frontiers in Immunology 12.
Crossref
Crossref
Sheila Sánchez Castillo, Lee Smith, Arturo Díaz Suárez & Guillermo Felipe López Sánchez. (2021) Association between Physical Activity and Comorbidities in Spanish People with Asthma-COPD Overlap. Sustainability 13:14, pages 7580.
Crossref
Crossref
Jian-jun Wu, Hong-ri Xu, Ying-xue Zhang, Yi-xuan Li, Hui-yong Yu, Liang-duo Jiang, Cheng-xiang Wang & Mei Han. (2020) The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Chee-Shee Chai, Sumastika Bt Mos, Diana-Leh-Ching Ng, Greta-Miranda-Kim-Choo Goh, Anselm-Ting Su, Muhammad Amin B. Ibrahim, Aisya Natasya Bt Musa, Seng-Beng Tan, Yong-Kek Pang & Chong-Kin Liam. (2020) Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia – a cross-sectional study. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Juan José Soler-Cataluña, Laura Novella, Cristina Soler, María Luisa Nieto, Violeta Esteban, Fernando Sánchez-Toril & Marc Miravitlles. (2020) Características clínicas y riesgo de agudizaciones asociados con diferentes criterios diagnósticos del solapamiento asma-EPOC. Archivos de Bronconeumología 56:5, pages 282-290.
Crossref
Crossref
Juan José Soler-Cataluña, Laura Novella, Cristina Soler, María Luisa Nieto, Violeta Esteban, Fernando Sánchez-Toril & Marc Miravitlles. (2020) Clinical characteristics and risk of exacerbations associated with different diagnostic criteria of asthma-COPD overlap. Archivos de Bronconeumología (English Edition) 56:5, pages 282-290.
Crossref
Crossref
Juan Luis Rodriguez Hermosa, Antonia Fuster Gomila, Luis Puente Maestu, Carlos Antonio Amado Diago, Francisco Javier Callejas González, Rosa Malo De Molina Ruiz, Manuel E Fuentes Ferrer, Jose Luis Álvarez Sala-Walther & Myriam Calle Rubio. (2020) Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study. JMIR mHealth and uHealth 8:3, pages e15699.
Crossref
Crossref
Jian Kang, Jinping Zheng, Baiqiang Cai, Fuqiang Wen, Wanzhen Yao, Xiaoju Zhang, Yan Chen, Guansong Wang, Wen Li & Jie Cao. (2020) Current situation of asthma–COPD overlap in Chinese patients older than 40 years with airflow limitation: a multicenter, cross-sectional, non-interventional study. Therapeutic Advances in Respiratory Disease 14, pages 175346662096169.
Crossref
Crossref
Marta Rzadkiewicz & Jacek Nasiłowski. (2019) Psychosocial Interventions for Patients with Severe COPD—An Up-to-Date Literature Review. Medicina 55:9, pages 597.
Crossref
Crossref
Raffaele Antonelli Incalzi, Giorgio Walter Canonica, Nicola Scichilone, Sara Rizzoli, Lucia Simoni & Francesco Blasi. (2019) The COPD multi-dimensional phenotype: A new classification from the STORICO Italian observational study. PLOS ONE 14:9, pages e0221889.
Crossref
Crossref
Franziska Roth-Walter, Ian M. Adcock, Cristina Benito-Villalvilla, Rodolfo Bianchini, Leif Bjermer, Gaetano Caramori, Luigi Cari, Kian Fan Chung, Zuzana Diamant, Ibon Eguiluz-Gracia, Edward F. Knol, Antonios G. A. Kolios, Francesca Levi-Schaffer, Giuseppe Nocentini, Oscar Palomares, Pier Giorgio Puzzovio, Frank A. Redegeld, Betty C. A. M. van Esch & Cristiana Stellato. (2019) Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper. Allergy 74:3, pages 432-448.
Crossref
Crossref
Myriam Calle Rubio, Juan José Soler-Cataluña, José Luis López-Campos, Bernardino Alcázar Navarrete, José Miguel Rodríguez González-Moro, Joan B. Soriano, Manuel E. Fuentes Ferrer & Juan Luis Rodriguez Hermosa. (2019) Assessing the clinical practice in specialized outpatient clinics for chronic obstructive pulmonary disease: Analysis of the EPOCONSUL clinical audit. PLOS ONE 14:2, pages e0211732.
Crossref
Crossref
Jian-Jun Wu, Hong-Ri Xu, Ying-Xue Zhang, Yi-Xuan Li, Hui-Yong Yu, Liang-Duo Jiang, Cheng-Xiang Wang & Mei Han. (2019) The characteristics of the frequent exacerbators with chronic bronchitis phenotype and the asthma-chronic obstructive pulmonary disease overlap syndrome phenotype in chronic obstructive pulmonary disease patients. Medicine 98:46, pages e17996.
Crossref
Crossref
Zênia T.S. Araujo, Karla M.P.P. Mendonça, Bruma M.M. Souza, Tacito Z.M. Santos, Gabriela S.S. Chaves, Brenda N.G. Andriolo & Patricia A.M.S. Nogueira. (2019) Pulmonary rehabilitation for people with chronic obstructive pulmonary disease. Medicine 98:38, pages e17129.
Crossref
Crossref
Susana Conde Diez, Ana Viejo Casas, Juan Luis Garcia Rivero, Juan Carlos Lopez Caro, Felix Ortiz Portal & Gualberto Diaz Saez. (2019) Impact of a homeopathic medication on upper respiratory tract infections in COPD patients: Results of an observational, prospective study (EPOXILO). Respiratory Medicine 146, pages 96-105.
Crossref
Crossref
I. V. Leshchenko. (2018) Possibilities and limitations of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease. Russian Pulmonology 28:5, pages 602-612.
Crossref
Crossref
M. T. Driessen, J. Whalen, B. Seewoodharry Buguth, L. A. Vallejo-Aparicio, I. P. Naya, Y. Asukai, B. Alcázar-Navarrete, M. Miravitlles, F. García-Río & N. A. Risebrough. (2018) Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective. Respiratory Research 19:1.
Crossref
Crossref
Myriam Calle Rubio, Juan Luis Rodríguez Hermosa, Juan José Soler-Cataluña, José Luis López-Campos, Bernardino Alcazar Navarrete, Joan B. Soriano, José Miguel Rodríguez Gónzalez-Moro, Manuel E. Fuentes Ferrer & Marc Miravitlles. (2018) Atención médica según el nivel de riesgo y su adecuación a las recomendaciones de la guía española de la enfermedad pulmonar obstructiva crónica (EPOC) (GesEPOC): Estudio EPOCONSUL. Archivos de Bronconeumología 54:5, pages 270-279.
Crossref
Crossref
Myriam Calle Rubio, Juan Luis Rodríguez Hermosa, Juan José Soler-Cataluña, José Luis López-Campos, Bernardino Alcazar Navarrete, Joan B. Soriano, José Miguel Rodríguez Gónzalez-Moro, Manuel E. Fuentes Ferrer & Marc Miravitlles. (2018) Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (GesEPOC): The Epoconsul Study. Archivos de Bronconeumología (English Edition) 54:5, pages 270-279.
Crossref
Crossref
Marc Miravitlles, Borja G. Cosío, Aurelio Arnedillo, Myriam Calle, Bernardino Alcázar-Navarrete, Cruz González, Cristóbal Esteban, Juan Antonio Trigueros, José Miguel Rodríguez González-Moro, José Antonio Quintano Jiménez & Adolfo Baloira. (2017) A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease. Respiratory Research 18:1.
Crossref
Crossref